Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy
Conditions: Malignant Neoplasm of Bladder; Muscle Invasive Bladder Carcinoma Interventions: Drug: Neoadjuvant Chemotherapy; Procedure: Partial cystectomy with Extended pelvic lymph node dissection; Drug: Adjuvant systemic therapy Sponsors: Case Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
Conditions: Triple Negative Breast Cancer Interventions: Drug: Cyclophosphamide; Drug: Epirubicin; Drug: Docetaxel; Drug: Carboplatin; Procedure: Breast Surgery; Drug: Capecitabine Sponsors: University of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Efficacy of Olanzapine on Weight Gain in Women With Advanced Stage Gynecologic Cancer Receiving Paclitaxel and Carboplatin Combination Chemotherapy : a Double Blind, Placebo-controlled Randomized Trial
Conditions: Weight Gain Interventions: Drug: Olanzapine 5 MG Sponsors: Rajavithi Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Conditions: Cervical Cancer; Neoadjuvant Chemoimmunotherapy; Fertility Preservation Interventions: Drug: Camrelizumab; Drug: Cisplatin; Drug: Nab paclitaxel; Procedure: biopsy Sponsors: Tongji Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Women Hospital, School of Medicine, Zhejiang University; Third Military Medical University; Beijing Friendship Hospital; Sichuan Cancer Hospital and Research Institute; Tianjin Medical University; West China Second University Hospital; Xiangya Hospital of Central South University; Qilu Hospital of Shandong University; Gansu Cancer Hospital; Zhejiang Cancer Hospital; S...
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Glycocalyx Monitoring in Major Abdominal Surgery
Conditions: Major Abdominal Surgery Interventions: Procedure: Cytoreduction surgery with Hyperthermic Intraperitoneal Chemotherapy; Procedure: Cephalic DuodenoPancreatectomy Sponsors: University Hospital, Rouen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Gestional Trophoblastic Neoplasia Ultrasound Assessment: Titanium Study
Conditions: Describe Typical Gray Scale/Color Doppler Ultrasound Features of Gestational Trophoblastic Neoplasia at the US Examination; To Assess if There Are Differences at the Baseline US Scan Between Low-risk and High-risk Patients; To Identify Ultrasound Predictors of Resistance to First-line Single Drug Chemotherapy in Low-risk GTN Patients; To Investigate if Machine Learning (ML) Algorithms (Radiomics, Deep Neural Networks (DNN), and Other Machine Learning Algorithms Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer
Conditions: Locally Advanced Gastric Carcinoma; HER2 Negative; Efficacy; Safety Interventions: Drug: Tirolizumab+SOX/XELOX; Drug: SOX/XELOX Sponsors: Lin Chen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
Conditions: Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer Interventions: Drug: Thalidomide+cetuximab+FOLFOX/FOLFIRI Sponsors: Xinqiao Hospital of Chongqing; Chongqing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
Conditions: Colorectal Cancer Metastatic Interventions: Drug: Adebrelimab; Drug: Oxaliplatin; Drug: Capecitabine; Drug: Bevacizumab Sponsors: The Fourth Affiliated Hospital of Zhejiang University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer
Conditions: Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence Interventions: Drug: Adebrelimab, Apatinib, Gemcitabine, cisplatin Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
Conditions: Acute Myeloid Leukemia Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspirate; Other: Electronic Health Record Review Sponsors: Mayo Clinic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery
Conditions: Breast Cancer; Triple Negative Breast Cancer; HER2-positive Breast Cancer; Neoadjuvant Chemotherapy Interventions: Procedure: Omission of surgical treatment Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy
Conditions: Cancer Interventions: Behavioral: Exercise; Behavioral: Health Behaviour Change (Pedometer) Sponsors: University of Dublin, Trinity College; St. James ' s Hospital, Ireland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma; Efficacy; Toxicity Interventions: Drug: Induction Immunotherapy-Toripalimab; Drug: Induction Chemotherapy-Albumin-paclitaxel combined with cisplatin; Radiation: Radiotherapy; Drug: Apatinib; Drug: Capecitabine Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5
Conditions: Follicular Lymphoma Interventions: Drug: Mosunetuzumab; Drug: Lenalidomide; Drug: Rituximab; Drug: Obinutuzumab; Drug: Cyclophosphamide; Drug: Doxorubicin; Drug: Vincristin; Drug: Prednisone; Drug: Rituximab; Drug: Obinutuzumab; Drug: Bendamustin Sponsors: The Lymphoma Academic Research Organisation; Lymphoma Study Association; Swiss Group for Clinical Cancer Research; Grupo Espa ñol de Linfomas y Transplante Autólogo de Médula Ósea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
